Sole 1

Cover Block

Name	Sole 1
Tagline	AI-powered robotic socks with synthetic muscles to restore mobility and prevent falls for people with foot drop. [James Dyson Award, 2025]
Headquarters	Cambridge, United States [LinkedIn (company post), May 2025]
Founded	2025
Stage	Pre-Seed
Business Model	Hardware + Software
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Academic Spinout [Boston University News Service, 2026]
Funding Label	Undisclosed

Links

• Website: https://thesole1.com
• LinkedIn: https://www.linkedin.com/company/sole1

Executive Summary

Sole 1 is a pre-seed healthtech venture developing a soft, AI-powered robotic sock to restore mobility for individuals with foot drop. The company originated as a student project at Harvard, winning the US 2025 James Dyson Award [James Dyson Award, 2025]. Its product, branded Sole¹, differentiates from rigid orthotics by using fabric-embedded synthetic muscles and AI-based gait tracking to both assist and rehabilitate movement [James Dyson Award, 2025].

Founders Bradley Wagman and Viktor Bokisch have steered the project from academic concept to award-winning prototype. No formal venture funding rounds have been publicly disclosed. The critical watchpoints over the next 12-18 months are the company's ability to secure its first institutional capital, initiate regulatory clearance processes, and move from user testing to initial commercial partnerships.

Data Accuracy: YELLOW -- Core product claims and founding story are confirmed by award and university sources; funding and team details beyond the founders are not independently corroborated.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	Hardware + Software
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding	Undisclosed

How the Company Got Here

Sole 1 is a medical device startup founded in 2025 by Harvard engineering students Bradley Wagman and Viktor Bokisch [Boston University News Service, 2026]. The company is based in Cambridge, Massachusetts, and emerged from a student-led project focused on developing a soft robotic solution for foot drop. Its primary public milestone came later that year when its product, Sole¹, was named the US 2025 James Dyson Award National Winner [James Dyson Award, 2025].

Data Accuracy: YELLOW -- Founders and headquarters confirmed by a university news service; founding year and award status confirmed by primary award source.

Product and Technology

Sole 1's core proposition is a hardware and software system designed to address foot drop, a condition often resulting from stroke, multiple sclerosis, or other neurological injuries [James Dyson Award, 2025]. The device aims to track, train, and physically assist walking to prevent falls and support nerve recovery [Perplexity Sonar Pro Brief, retrieved 2024].

Unlike traditional rigid ankle-foot orthoses (AFOs) or bulkier exoskeletons, Sole¹ uses fabric-embedded synthetic muscles to provide dynamic physical assistance [Perplexity Sonar Pro Brief, retrieved 2024]. An integrated AI system is tasked with orchestrating the wearer's gait in real-time [James Dyson Award / YouTube, 2025].

Data Accuracy: YELLOW -- Product claims are consistent across the James Dyson Award materials and company social media, but technical specifications and development status are not independently verified.

Where the Demand Sits

The market for foot drop treatment devices is defined by a persistent, unmet clinical need for comfortable, active rehabilitation tools. The condition affects an estimated 1 in 5 stroke survivors and is a common complication of multiple sclerosis, spinal cord injury, and other neurological disorders [GII Research, 2026].

Metric	Value
Global Market 2024	0.9 $B
Global Market 2030 (projected)	1.2 $B
CAGR 2024-2030	7.8 %

Data Accuracy: YELLOW -- Market sizing from a single third-party report; clinical prevalence and growth drivers are consistent with broader industry analysis.

Competitive Landscape

Sole 1 enters a rehabilitation hardware market defined by established medical devices and a newer wave of tech-forward challengers. Competition for Sole 1's robotic sock can be mapped across three distinct segments: traditional, passive ankle-foot orthoses (AFOs) from companies like Ottobock and Fillauer; functional electrical stimulation (FES) devices like the Bioness L300 or Cionic Neural Sleeve; and clinical-grade robotic exoskeletons [GII Research, 2026; Reddit, 2026].

Sole 1's current edge is anchored in its unique integration of fabric-embedded synthetic muscles and AI-driven gait orchestration. The James Dyson Award recognition provides a signal of technical innovation [James Dyson Award, 2025].

Data Accuracy: YELLOW -- Competitive mapping is inferred from general market reports and user discussions; no direct competitor citations from the company are available.

Opportunity

If Sole 1 can translate its award-winning prototype into a cleared medical device, it targets a multi-billion dollar market for a condition with chronic, underserved demand. The headline opportunity is to become the first widely adopted, soft-robotic alternative to traditional AFOs [James Dyson Award, 2025].

Scenario	What happens	Catalyst	Why it's plausible
Direct-to-Consumer Rehab	Sole¹ is prescribed by neurologists and physiatrists as a premium, patient-owned rehabilitation device.	Securing FDA 510(k) clearance as a powered orthosis.	The device is framed as a mobility and recovery aid [Boston Globe, September 2025].
Institutional Land-and-Expand	Sole 1 first sells into top-tier rehabilitation hospitals and MS treatment centers.	A pivotal clinical study partnership with a major academic medical center.	Early materials emphasize clinical testing and rehabilitation [James Dyson Award, 2025].
Platform Expansion	The core synthetic muscle and AI gait engine is licensed or adapted for adjacent mobility impairments.	Successful user data from the initial foot drop cohort.	The technology's premise is dynamic, AI-driven assistance [Perplexity Sonar Pro Brief].

Data Accuracy: YELLOW -- The market size and competitive context are cited from industry reports. The company's specific path to scale and compounding effects are inferred from its public product claims and award materials.

The Analyst's Last Word

Verdict: PASS / WATCH / PROCEED,... Conviction:... Time horizon:...

Agentic / AI relevance

Sole 1 utilizes AI-based gait tracking and orchestration to manage synthetic muscle activation in real-time.

Sources

1. [James Dyson Award, 2025] Sole¹ | James Dyson Award, https://www.jamesdysonaward.org/en-US/2025/project/sole
2. [James Dyson Award / YouTube, 2025] Sole¹ | US 2025 James Dyson Award National Winner, https://www.youtube.com/watch?v=MyjJWaiLLoY
3. [LinkedIn (company post), May 2025] Sole 1 James Dyson Award announcement, https://www.linkedin.com/posts/sole1_sole1-jamesdysonaward-footdrop-activity-7374119303853387776-_Vfz
4. [Boston Globe, September 2025] Harvard engineering students create robotic sock for disabled people, https://www.bostonglobe.com/2025/09/15/business/harvard-robotic-sock-ai/
5. [Boston University News Service, 2026] From robotics class to start-ups: Meet the engineering students who are modernizing mobility devices, https://bunewsservice.com/from-robotics-class-to-start-ups-meet-the-engineering-students-who-are-modernizing-mobility-devices/
6. [Facebook (Harvard GSD), 2026] Sole 1, developed by Bradley Scott Wagman (MDE '26)..., https://www.facebook.com/HarvardGSD/posts/sole-1-developed-by-bradley-scott-wagman-mde-26-ceo-and-co-founder-alongside-vik/1439003011594925/
7. [Reddit, 2026] r/MultipleSclerosis on Reddit: Bioness vs. Cionic opinions and experiences with foot drop and unstable gait?, https://www.reddit.com/r/MultipleSclerosis/comments/1cuk26s/bioness_vs_cionic_opinions_and_experiences_with/
8. [GII Research, 2026] Foot Drop Treatment Devices Global Market Report 2026, https://www.giiresearch.com/report/tbrc1945216-foot-drop-treatment-devices-global-market-report.html
9. [Perplexity Sonar Pro Brief] Sole 1 product claims, retrieved 2024